Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 9 articles:
HTML format



Single Articles


    September 2024
  1. SANDS BE, Feagan BG, Peyrin-Biroulet L, Danese S, et al
    Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
    N Engl J Med. 2024;391:1119-1129.
    PubMed     Abstract available


    August 2024
  2. GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al
    Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
    N Engl J Med. 2024;391:434-441.
    PubMed     Abstract available


    July 2024
  3. ABRAHAM C
    Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.
    N Engl J Med. 2024;391:275-277.
    PubMed    


  4. PEYRIN-BIROULET L, Chapman JC, Colombel JF, Caprioli F, et al
    Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
    N Engl J Med. 2024;391:213-223.
    PubMed     Abstract available


    August 2023

  5. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;389:772.
    PubMed    


    June 2023
  6. D'HAENS G, Dubinsky M, Kobayashi T, Irving PM, et al
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med. 2023;388:2444-2455.
    PubMed     Abstract available


    May 2023
  7. ABREU MT
    JAK1 Inhibition to Treat Crohn's Disease.
    N Engl J Med. 2023;388:2005-2009.
    PubMed    


  8. LOFTUS EV JR, Panes J, Lacerda AP, Peyrin-Biroulet L, et al
    Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
    N Engl J Med. 2023;388:1966-1980.
    PubMed     Abstract available


    March 2023
  9. TRAVIS S, Silverberg MS, Danese S, Gionchetti P, et al
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med. 2023;388:1191-1200.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.